Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03698513 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects
A Phase 1 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 1
- Development phase
- 113
- Enrollment target
NCT03698513 is a Phase 1 study that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 113 participants.
The verdict
NCT03698513, a Phase 1 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 113 participants
- Enrollment target
Study Summary
This study will investigate the safety and interaction of BMS-986177 in healthy volunteers, when administered with Aspirin and/or Clopidogrel
Interventions
- DRUG Aspirin
- DRUG Clopidogrel
- DRUG BMS-986177
- OTHER Placebo (for BMS-986177)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2018-10-04 |
| Est. Completion | 2019-02-19 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03698513
The ClinicalTrials.gov registry entry for NCT03698513 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Aspirin is the first listed.
NCT03698513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03698513 about?
NCT03698513 is a clinical study titled "A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects". This study will investigate the safety and interaction of BMS-986177 in healthy volunteers, when administered with Aspirin and/or Clopidogrel
What is the current status of trial NCT03698513?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 113 participants. The study started on 2018-10-04. Estimated completion is 2019-02-19.
What interventions are being tested in trial NCT03698513?
The interventions under investigation include: Aspirin (DRUG), Clopidogrel (DRUG), BMS-986177 (DRUG), Placebo (for BMS-986177) (OTHER).
Who is sponsoring clinical trial NCT03698513?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.